FTC Allows J&J To Buy Pfizer Unit If It Sells 4 Brands

Law360, New York (December 13, 2006, 12:00 AM EST) -- A day after Johnson & Johnson secured approval from the European Union to continue its acquisition of Pfizer Inc.’s Consumer Healthcare unit, the companies agreed to sell more businesses in the United States to appease the Federal Trade Commission.

J&J first announced that it would acquire Pfizer Consumer Healthcare for $16.6 billion in June, saying the deal would create the world’s premier consumer health care company.

“This acquisition builds upon our broad base in health care products and our leadership objectives in the consumer, pharmaceutical and...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.